In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine ...

China is blaming the United States for the origin of COVID-19, accusing Washington of "evading responsibility" for the virus ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

China restated its case that Covid-19 may have originated in the United States in a white paper on its pandemic response ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Between the abrupt March resignation of CEO Rodney McMullen and other departures, Kroger has had the biggest changes among ...

The explanation for this treatment involves the cholinergic nervous system. The German scientists point out that SARS-CoV-2 ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

China on Wednesday accused the US for originating COVID-19, claiming America was trying to "shift the blame" after US ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

In February, the HHS unexpectedly delivered notice that the South San Francisco-based company was to stop all work on the ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...